The VP, Corp. Contr of Integer Holdings Corporation (NYSE: ITGR) is Buying Shares

By Carrie Williams

Yesterday, the VP, Corp. Contr of Integer Holdings Corporation (NYSE: ITGR), Thomas Mazza, bought shares of ITGR for $112.2K.

Following Thomas Mazza’s last ITGR Buy transaction on January 06, 2017, the stock climbed by 16.8%. This recent transaction increases Thomas Mazza’s holding in the company by 21.06% to a total of $312K.

Based on Integer Holdings Corporation’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $363 million and quarterly net profit of $13.69 million. In comparison, last year the company earned revenue of $347 million and had a net profit of $11.46 million. The company has a one-year high of $55.20 and a one-year low of $24.85. ITGR’s market cap is $1.49B and the company has a P/E ratio of 74.76.

Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $52.5, reflecting a -10.3% downside. Four different firms, including B.Riley FBR and Craig-Hallum, currently also have a Buy rating on the stock.

In the last 30 days, insiders have sold $1.43M worth of ITGR shares and purchased $283.5K worth of ITGR shares. The insider sentiment on Integer Holdings Corporation has been neutral according to 42 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Thomas Mazza’s trades have generated a -15.2% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Integer Holdings Corp. engages in manufacturing and developing medical devices and components. It operates through the following segments: Greatbatch Medical, QiG and Lake Region Medical. The Greatbatch Medical segment designs and manufactures products where Greatbatch either owns or licenses the intellectual property.